Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 16/20 | 0.62 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8292072 | 0.89 | PLA2G2A (0.61) | PLA2G2APLA2G1BALDH1A1GAAMAPT | |
| SCHEMBL27363618 | 0.88 | PLA2G2A (0.49) | PLA2G2APLA2G1BMAPTTP53 | |
| SCHEMBL7963412 | 0.88 | PLA2G2A (0.65) | PLA2G2APLA2G1BALDH1A1MAPTPKM | |
| SCHEMBL8301038 | 0.88 | PLA2G2A (0.71) | PLA2G2APLA2G1BALDH1A1GAAMAPT | |
| SCHEMBL7962188 | 0.85 | PLA2G2A (0.80) | PLA2G2A | |
| SCHEMBL7961660 | 0.82 | PLA2G2A (0.75) | PLA2G2APLA2G1BALDH1A1GAAMAPT | |
| SCHEMBL8645997 | 0.81 | PLA2G2A (0.83) | PLA2G2APLA2G1BALDH1A1MAPTPKM | |
| SCHEMBL14106891 | 0.81 | PLA2G2A (0.50) | PLA2G2APLA2G1BALDH1A1MAPTPKM | |
| SCHEMBL8292611 | 0.80 | PLA2G2A (0.60) | PLA2G2APLA2G1BGAAMAPTPKM | |
| SCHEMBL8291607 | 0.79 | PLA2G2A (0.68) | PLA2G2APLA2G1BALDH1A1MAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6252084-B1 | THERAPY FOR SEPSIS SHOCK | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| EP-0620215-B1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | LILLY CO ELI (US) | 1999-08-18 | — | — | EP | disclosed |
| US-5684034-A | INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE | ELI LILLY AND COMPANY (US) | 1997-11-04 | — | — | US | disclosed |
| EP-0620215-A1 | 1H-indole-3-acetamide derivatives as sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |